TAT and influenza: AdV.C3-Tat/HIV-Box ASer failed to induce significant inflammation in CR at high doses; however, when administered therapeutically after influenza infection, lethality, and ALI were mitigated in mice, as was ALI in CR, accompanied by a significant reduction in proinflammatory cytokine responses.